Subscriptions
  • Join our People's Pharmacy Page on Facebook
  • Follow JoeGraedon on Twitter
  • Follow Us
  • Free email newsletter

Print This Page

Where Did Contaminated Atorvastatin Come From?

  • Currently 4.7/5
  • 1
  • 2
  • 3
  • 4
  • 5
Not Helpful ..... Very Helpful
Was this information helpful? Average rating: 4.7/5 (99 votes)
What do you think? Click the stars to vote!
If you have more to say, post a comment below!

By now you no doubt know that a generic formulation of Lipitor (atorvastatin) made by the Indian company Ranbaxy was contaminated with small glass particles. The company announced its recall last week and we were among the first to report on it. Here is a link to our initial story about the Ranbaxy recall of atorvastatin.

What was not available until a few days ago was information about where the problem atorvastatin was actually made. Ranbaxy has manufacturing plants in at least eight countries including India and the U.S. This Indian company is now owned in large part by a Japanese company (following the money trail gets complicated) and exports drugs to over 100 countries around the world.

We have been searching to find out where the contaminated atorvastatin originated. Was it from a New Jersey plant or from a plant in India? According to pharmaceutical industry insiders (FiercePharma) the problem plant was an Indian manufacturing facility. According to FiercePharma, "The generic Lipitor that Ranbaxy Laboratories has recalled came out of an Indian plant that the FDA let out of the doghouse only 7 months ago." That's because this same company got into trouble with other generic drugs back in 2008 (see our prior story on this mess).

What was the problem with Ranbaxy products? Well, it turns out that the company fudged on data it submitted to the FDA. There were serious quality control questions about the manufacturing and monitoring process and over two dozen different products were banned from importation into the U.S. They included the cholesterol-lowering drugs simvastatin and pravastatin.

Since the Ranbaxy affair it has been revealed that there are serious problems with the approval and testing of drugs in India. Among other serious flaws, the Indian parliament discovered that drugs were approved without clinical trials. One wonders how many Indian manufacturing plants are inspected by the FDA as required by law. This is the same concern we have about chemical companies in China. The FDA has admitted that it only inspects a small fraction of the manufacturing facilities in China, India or dozens of other countries. This means that oversight leaves much to be desired.

We are beginning to agree with many of the people who have posted on our website that more generic drugs should be made in the U.S. rather than in places where the FDA has little ability to inspect or monitor quality. We need jobs in the U.S. Why not make medicines here in plants that can be inspected on a regular basis?

In the meantime, there is likely to be a shortage of generic atorvastatin. According to Bloomberg:

"The recall by the drugmaker, based near New Delhi, may lead to a shortage of generic Lipitor in the U.S., Stephanie Yao, a spokeswoman for the Food and Drug Administration, said in an e- mail. The agency is working with other drugmakers to help fill the void in supply, she said.

"About 1 million prescriptions a week are written in the U.S. for generic copies of Lipitor, and Ranbaxy is the biggest supplier of the drug, according to data compiled by Bloomberg. Without Ranbaxy, Mylan Inc. (MYL) and Watson Pharmaceuticals Inc. (WPI) may be able to pick up a larger share of the market, said Bloomberg Industries analyst Asthika Goonewardene."

WHAT'S A PATIENT TO DO?

There is tremendous confusion in the marketplace about what to do with your Ranbaxy atorvastatin. Let's be perfectly clear. There IS a recall of 10-, 20- and 40 milligram pills from this company [see this link for the affected lot numbers]. That said, neither the FDA nor Ranbaxy have been forthcoming about whether there is a danger to patients. Because there is ambiguity, pharmacies may elect not to issue credit and dispense new non-Ranbaxy atorvastatin. We have heard from patients that when they requested either a generic atorvastatin from a different manufacturer or the brand name Lipitor, they were refused and told to just keep taking their Ranbaxy atorvastatin. We think that is crazy. If it has been determined that the identified lots have glass particles and should be returned to the manufacturer, then why should patients keep swallowing pills from these recalled lots? It is estimated that 3 to 4 millions Americans are taking Ranbaxy atorvastatin.

Here is our recommendation:

If you are taking atorvastatin (10-, 20- and 40-milligram pills), contact your pharmacist to find out whether it came from Ranbaxy and whether your pills are part of the recalled lots. Tell your pharmacist you will bring or send (in the case of mail-order pharmacies) the pills back in return for either Lipitor or non-recalled generic atorvastatin. Do NOT accept no for an answer. Your insurance company should make good and not require another co-pay for the substituted atorvastatin.

In the event of shortages of generic atorvastatin (a distinct possibility), you may need to ask for Lipitor or another statin-type drug to cover you during this period when Ranbaxy will be out of the game with its most popular atorvastatin dosage forms.

The sad reality of this recall is that once again confidence in generic drugs has been shaken. The FDA's ability to monitor generic drug manufacturing and quality is under question. Of course there have also been problems with brand name companies over the last few years. Johnson & Johnson got into trouble with products such as Motrin, Zyrtec, Tylenol and Benadryl at its plant in Fort Washington, PA.

If the FDA has trouble ensuring the quality of a major brand like Tylenol made in the U.S., it's hardly any wonder it has challenges in China and India where most of today's generic drugs are manufactured.

++++++++++++++++++++++++

If you found this information of value, you may wish to be notified about other health alerts or serious drug side effects. When you subscribe to our **free** online newsletter you will be periodically alerted to important stories, often before the mainstream media realizes what has happened. The newsletter offers questions and answers about drugs, home remedies, nutrition and non-drug approaches to healing; commentaries on the most pressing health issues of the day; special alerts on breaking health news as it happens and coverage of the top health headlines of the week.

It's easy to subscribe to our online newsletter. Just enter your email address in the white box on the upper right corner of this page just under Free email newsletter. It's also easy to find us on Facebook and Twitter or sign up for the free podcast of our weekly radio shows. Stay informed with us, The People's Pharmacy.

  • Currently 4.7/5
  • 1
  • 2
  • 3
  • 4
  • 5
Not Helpful ..... Very Helpful
Was this information helpful? Average rating: 4.7/5 (99 votes)
What do you think? Click the stars to vote!
If you have more to say, post a comment below!

6 Comments

| Leave a comment

A very detailed submission, however it's implication on ranbaxy's share price is open to high speculation

Only those with the genetic cholesterol problems should be on these drugs anyway so a shortage is a great benefit to mankind!

Most people do NOT need to take these drugs to lower their cholesterol. My hubby got his down 100 points with just eliminating all unnatural oils.

As long as the numbers are between 200-300 they are OK. Studies of centenarians have proved this. If cholesterol in the mid 200s was a killer they would never have survived to 100 years old!

Use organic coconut, palm, and other natural oils instead of the corn and other types of grocery store oils. We use sesame or avocado oil for our mayonnaise and save drippings from our organic bacon to cook with. Extra virgin olive oil is great too.

The lowering process will take a few years and will depend on how much you eat out.

Face it. Lipitor and other statins are dangerous regardless of where they come from or whether they have ground glass in them. Their side effects, from muscle pain to ALS-like paralysis have been well-documnted.

My father lives in an assited living establishment, where he receives atorvastatin. At about the same time that I read your Alert, I also received a letter from his Part D Provider stating that he had not been refilling his atorvastatin. That was a mistake on their part, though no one could explain the letter or the mistake to me. Then I realized what the medication was and questioned them about that. The response to that question was equally vague. So, I talked to the medication and healthcare staff where he lives and they knew even less than I did. So, I called the company which provides the medicine. They assured me that he was taking the medicine. I told them that wasn't the problem but the fact that it had been recalled was the problem. It seemed to be news to them; they assured me that either he would continue to take atorvastatin or it would be replaced with something else. I would know by the EOB from the Part D provider or by continuing to heckle to staff where he lives.

I suppose I could just stop taking your newsletter and be just as fat, dumb and happy as every professional I've talked to.

This is crazy! We limit drugs from Canada which has a much more robust inspection system, and let in stuff from a bad actor like Ranbaxy. We need to get on Congress to give more money and slots to the FDA so they can do their job!

I retired from Fed Ex as a courier of 22 years at age 55. I have had two very physical jobs since age 16. In Jan. of 2012 my doctor felt it necessary to put me on generic Lipitor manufactured by Ranbaxy of India. I was active and in generally good health...weighing 180 pounds at a height just under 6 feet.

After one month of use I developed muscle cramps in my calves. I took myself off the drug for a month while waiting to see my doctor. The cramps went away. He felt the benefits outweighed the risks.

I went back on from March until September when I noticed muscle fasciculations in my left shoulder muscle which rapidly spread throughout my body below my neck .I saw a neurologist for an EMG and full spinal MRI on Oct.1st. Bloodwork was fine.

I was told I had definite nerve and muscle damage.A second EMG was scheduled for Dec.10th. By then I was experiencing severe occassional cramping along with the fasciculations that are constant. I was also suffering major gait disturbances. I was diagnosed with ALS.

It is now early January and I can only walk short distances. I am deteriorating at a fairly fast pace. Last Summer I was playing recreational Softball, Tennis, Cycling, and Hiking locally. Now I am apparently in the process of dying.

I have leftover Atorvastatin from this company in India that has a history of problems with the FDA. I would love to find a lab willing to test it.

I am CONVINCED this drug is responsible for my ALS. I would also volunteer for any testing to confirm a link between this horrible drug and ALS.

PEOPLE'S PHARMACY RESPONSE:

We fear that it may not be the particular atorvastatin...but statins in general that might be associated with ALS. We have received hundreds of reports of such a link. The FDA even investigated this, but decided that there was no connection. We think some people are very susceptible to statin-type side effects and may go on to develop ALS as a result. The speed with which you developed this condition is very alarming. We are very sorry for what you are going through. We only wish the FDA would take stories such as yours more seriously.

Leave a comment

Share your comments or questions with the People's Pharmacy online community. Not all comments will be posted. Advice from other visitors to this web site should not be considered a substitute for appropriate medical attention. Concerns about medications should be discussed with a health professional. Do not stop any medication without first checking with your physician.

Check this box to be notified by email when follow-up comments are posted.